BACKGROUND: The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to identify the risk factors for VTE after lung transplantation. METHODS: We performed a nested case-control study within the cohort of 121 patients who underwent lung transplantation at our center between August 2001 and July 2005. Control subjects were matched to case patients on the number of days from the time of transplant. Cox proportional hazards models were used to identify risk factors for VTE. RESULTS: Twenty-four patients had deep vein thromboses, and 6 patients had pulmonary emboli (3 patients had both) [22% of the cohort]. In multivariate models, older age (p < 0.05), diabetes mellitus (p = 0.03), and pneumonia (p = 0.02) were associated with a higher rate of VTE. CONCLUSIONS: VTE is a frequent complication of lung transplantation. Older age, diabetes, and pneumonia increase the rate of VTE. Future studies of intensive VTE prophylaxis may be warranted.
BACKGROUND: The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to identify the risk factors for VTE after lung transplantation. METHODS: We performed a nested case-control study within the cohort of 121 patients who underwent lung transplantation at our center between August 2001 and July 2005. Control subjects were matched to case patients on the number of days from the time of transplant. Cox proportional hazards models were used to identify risk factors for VTE. RESULTS: Twenty-four patients had deep vein thromboses, and 6 patients had pulmonary emboli (3 patients had both) [22% of the cohort]. In multivariate models, older age (p < 0.05), diabetes mellitus (p = 0.03), and pneumonia (p = 0.02) were associated with a higher rate of VTE. CONCLUSIONS:VTE is a frequent complication of lung transplantation. Older age, diabetes, and pneumonia increase the rate of VTE. Future studies of intensive VTE prophylaxis may be warranted.
Authors: Jonathan P Singer; Meng-Yu Huang; Christine Hui; Paul D Blanc; Rebecca F Boettger; Jeffery Golden; Katherine Watkins; Charles Hoopes; Lorriana E Leard Journal: J Heart Lung Transplant Date: 2010-06-08 Impact factor: 10.247
Authors: Carles Bravo; Joaquim Majó; Fernando Ruiz; Laura Muntaner; Víctor Monforte; Joan Solé; José Maestre; Ferran Morell; Antonio Roman Journal: J Transplant Date: 2009-05-25
Authors: Elizabeth J Bell; Elizabeth Selvin; Pamela L Lutsey; Vijay Nambi; Mary Cushman; Aaron R Folsom Journal: Vasc Med Date: 2013-10 Impact factor: 3.239
Authors: Manuel L Ribeiro Neto; Marie Budev; Daniel A Culver; C Randall Lane; Marcelo Gomes; Xiao-Feng Wang; Paulo Novis Rocha; Mitchell A Olman Journal: Transplantation Date: 2018-04 Impact factor: 4.939
Authors: Holly Mansell; Ahmed Shoker; Jane Alcorn; Mark E Fenton; Julian S Tam; William Semchuk; Babar Bashir; Walter K Kraft; Shenzhen Yao; James D Douketis Journal: Clin Transl Sci Date: 2022-05-02 Impact factor: 4.438
Authors: Hailey M Shepherd; Ramsey R Hachem; Chad A Witt; Rodrigo V Guillamet; Derek E Byers; Benjamin D Kozower; Bryan F Meyers; Tsuyoshi Takahashi; G Alexander Patterson; Varun Puri; Daniel Kreisel; Ruben G Nava Journal: J Thorac Dis Date: 2022-08 Impact factor: 3.005